Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reading Rheum

Mary Corr, MD; Michael M. Ward, MD  |  Issue: April 2007  |  April 1, 2007

Cadherin-11 May Be a Therapeutic Target in RA

By Mary Corr, MD

Lee DM, Kiener HP, Agarwal SK, et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science. 2007;315(5814):1006-1010.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Abstract

The normal synovium forms a membrane at the edges of joints and provides lubrication and nutrients for cartilage. In RA, the synovium is the site of inflammation, and it participates in an organized tissue response that damages cartilage and bone. We identified cadherin-11 as essential for development of the synovium. Cadherin-11–deficient mice have a hypoplastic synovial lining, display a disorganized synovial reaction to inflammation, and are resistant to inflammatory arthritis. Cadherin-11 therapeutics prevent and reduce arthritis in mouse models. Thus, synovial cadherin-11 determines the behavior of synovial cells in their proinflammatory and destructive tissue response in inflammatory arthritis.

Commentary

RA is a debilitating disease marked by bone and cartilage destruction. In the rheumatoid synovium, the fibroblast cells aggressively proliferate and invade the other joint structures. Indeed, these fibroblast-like synoviocytes develop genetic and phenotypic features similar to malignant cells, including expression of proto-oncogenes and loss of contact growth inhibition. Although these cells in the pannus locally invade, they never metastasize. Most of the current therapies for RA are directed toward other components of the immune system. There has been limited investigation into therapies that are directed against the aggressive behavior of the synovial fibroblasts. By targeting cadherin-11, an essential adhesion molecule for synovial development and mature architecture, Lee and colleagues are paving the way for another approach in our therapeutic armamentarium.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 1. Synovial fibroblasts express functional cadherin-11. A and B: Normal synovium stained with either control (A) or anti-cadherin–11 (B) antisera. (Magnification, 650.) C and D: Arthritic K/BxN synovium. Synovial pannus invading cartilage stained with either control (C) or anti-cadherin–11 (D) antisera is shown. There is intense cellular reactivity at the bone/pannus interface. (Magnification, 400x.) Key: P, pannus; C, cartilage; B, bone.
Source: Science. 2007;315(5814):1007.

In a normal diarthrodial joint, the synovial lining is composed of synoviocytes that form an intact layer through cell-to-cell contacts with intervening matrix spaces. Cadherins are a family of adhesion molecules that bind to other cadherin molecules on neighboring cells. Cadherin-11 has a key role in mediating fibroblast-like synoviocyte intercellular adhesion and synovial tissue organization. (See Figure 1) Mice that are genetically deficient in cadherin-11 have a hypoplastic synovial lining. When challenged with arthritogenic antibodies, cadherin-11–deficient mice developed less paw swelling than normal mice and the synovial tissue appeared to lack the usual dense organization on histological examination. In this experiment, fibroblasts in the local microenvironment appeared necessary for the full function of other cell types in the inflammatory process.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:anti-tumor necrosis factorReading RheumResearchRheumatoid Arthritis (RA)spondylarthropathyTreatmentUveitis

Related Articles

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    New Therapeutics for Osteoarthritis May Be in Sight

    April 1, 2015

    Overview of OA pathogenesis, recent discoveries suggest new treatment strategies are possible

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences